| AD | Alzheimer’s disease |
| ADAM | A disintegrin and metalloproteinase |
| APP | Amyloid precursor protein |
| AS-IV | Astragaloside IV |
| BACE | β-site beta-secretase |
| BDNF | Brain-derived neurotropic factor |
| cryo-EM | Cryo-electron microscopy |
| COX-2 | Cyclooxygenase-2 |
| CT | Cryptotanshinone |
| DLB | Dementia with Lewy bodies |
| ERK | Extracellular signal-regulated kinase |
| FTLD | Frontotemporal dementia |
| GSI | γ-secretase inhibitors |
| GSMs | γ-secretase modulators |
| GFAP | Glial fibrillary acidic protein |
| iNOS | Inducible nitric oxide synthase |
| MAPT | Microtubule-associated protein tau |
| MCI | Mild cognitive impairment |
| MDA | Malondialdehyde |
| NICD | Notch intracellular domains |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| NF-kBp65 | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| n-BP | n-Butylidenephthalide |
| OB | Onjisaponin B |
| PSEN-1 | Presenilin-1 |
| PSEN-2 | Presenilin-2 |
| PDAPP | PDGF promoter driven amyloid precursor protein |
| PPAR | Peroxisome proliferator-activated receptor |
| SCD | Subjective cognitive decline |
| TIIA | Tanshinone IIA |
| VaD | Vascular dementia |
| 8-OHdG | 8-hydroxy-2′deoxyguanosine |